British America Tobacco Group


Kentucky Bioprocessing Selects Meridian Clinical Research to Conduct Phase I Influenza Vaccine Clinical Trial of KBP-V001

Kentucky Bioprocessing (KBP) (owned by British American Tobacco) recently launched a clinical trial to test its seasonal flu vaccine candidate. Working with research site organization Meridian Clinical Research, the sponsor and principal investigator will be...

Pin It on Pinterest